首页|心脉舒一号口服液治疗心脏病分子机制网络药理学研究

心脉舒一号口服液治疗心脏病分子机制网络药理学研究

扫码查看
目的 探讨心脉舒一号口服液治疗心脏病的作用机制。方法 通过中药系统药理学数据库与分析平台(TCMSP)获取生地黄、天冬、麦冬、酸枣仁、柏子仁、丹参、当归、太子参、茯苓、白芍、五味子11味中药材的活性成分,并进行蛋白质靶点预测;通过GeneCards数据库获取心脏病的相关疾病靶点,通过Venny 2。1。0平台筛选出心脉舒一号口服液活性成分与心脏病的共有靶点;通过Cytoscape 3。9。1软件构建药物-活性成分-靶点网络图及活性成分-疾病靶点网络图,并分析其核心成分;通过String 11。0数据库构建蛋白-蛋白互作(PPI)网络,经Cytoscape 3。9。1软件筛选出关键靶点及核心靶点;通过Metascape数据库进行京都基因与基因组百科全书(KEGG)通路富集分析及基因生物过程(GO)功能分析;对核心成分与核心靶点进行分子对接验证。结果 共收集到活性成分169种,关键靶点37个,疾病靶点1 097个,活性成分-疾病共有靶点197个。核心成分为槲皮素、木犀草素、熊果酸,核心靶点为环氧合酶2(PTGS2)、钠电压门控通道α亚基5(SCN5A)、溶质载体家族6成员2(SLC6A2)。共获得KEGG信号通路17条,主要涉及蛋白解旋酶癌、人类巨细胞病毒感染、晚期糖基化终末产物-晚期糖基化终末产物多配体受体(AGE-RAGE)信号通路等;GO功能分析条目1 205条,包括生物学过程(BP)944条、分子功能(MF)146条和细胞组分(CC)115条,主要涉及正调控血管内皮细胞迁移、老化、炎性反应、转录阳性调控-DNA模板化、基因表达的负调控、正调控细胞增殖等。分子对接结果显示,核心成分与其核心靶点均有较好的结合活性。结论 心脉舒一号口服液可通过多成分、多靶点、多通路治疗心脏病。
Molecular Mechanism of Xinmaishuyihao Oral Liquid in the Treatment of Heart Disease Based on Network Pharmacology
Objective To investigate the molecular mechanism of Xinmaishuyihao Oral Liquid in the treatment of heart disease.Methods The active ingredients of 11 traditional Chinese medicines(including Rehmanniae Radix,Asparagus Radix,Ophiopogonis Radix,Ziziphi Sujuba Semen,Platycladi Semen,Salviae Miltiorrhizae Radix,Angelicae Sinensis Radix,Pseudostellariae Radix,Cocos Poria,Paeoniae Alba Radix,and Schisandrae Chinensis Fructus)were obtained through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP).Protein target prediction was performed.The disease targets related to heart disease were obtained from the GeneCards database,and the Venny 2.1.0 software was used to screen the common targets between the active components of Xinmaishuyihao Oral Liquid and heart disease.The Cytoscape 3.9.1 software was used to construct the network diagram of Xinmaishuyihao Oral Liquid-active components-predicted targets and the network diagram of active components-disease targets,and their core components were analyzed.String 11.0 database was used to construct the protein-protein interaction(PP1)network,and Cytoscape 3.9.1 software was used to screen the key and core targets.Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analysis and Gene Ontology(GO)functional analysis were performed by the Metascape database.The core components and core targets were verified by molecular docking.Results A total of 169 active components and 37 key targets of active components-disease were collected.A total of 1 097 disease targets with 197 intersecting targets were collected.The core components were quercetin,luteolin,ursolic acid,etc.The core targets were PTGS2,SCN5A,SLC6A2,etc.A total of 17 KEGG signaling pathways were obtained,mainly involving proteoglycans in cancer,human cytomegalovirus infection,AGE-RAGE signaling pathway,etc.A total of 1 205 GO functional items were obtained,including 944 biological processes(BP),146 molecular functions(MF),and 115 cellular components(CC),mainly involving endothelium migration,aging,inflammatory response,positive regulation of transcription-DNA templating,negative regulation of gene expression,positive regulation of cell proliferation,etc.The molecular docking results showed that the core components had good binding activity with their core targets.Conclusion Xinmaishuyihao Oral Liquid can treat heart disease through multiple components,targets,and pathways.

Xinmaishuyihao Oral Liquidheart diseasenetwork pharmacologymolecular dockingmechanism

唐勇琛、张洪平、樊玲凤、杨玉竹、张亚洲

展开 >

广西壮族自治区柳州市中医医院·广西壮族自治区柳州市壮医医院,广西柳州 545000

广西壮族自治区柳州市中药<壮瑶药>制剂开发工程技术研究中心,广西柳州 545000

贵州中医药大学药学院,贵州贵阳 550025

心脉舒一号口服液 心脏病 网络药理学 分子对接 作用机制

广西壮族自治区柳州市科技计划项目

2020NBAA0807

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(17)